Adoption of revised code of conduct for the prevention of insider trading & code of corporate disclosure practice.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Ltd (Scrip Code: 541096) informed BSE that its Board of Directors adopted a revised Code of Conduct for Prevention of Insider Trading along with a Code of Corporate Disclosure Practices, including a Policy on determination of Legitimate Purpose, at a meeting held on November 12, 2025. The revision is done pursuant to Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The revised code has also been made available on the company's website at www.bplindia.in. The intimation was signed by Mr. Sharmin Soni, Company Secretary & Compliance Officer, from Vadodara.
This is a routine regulatory compliance update and does not have a direct material impact on shareholders or the stock price. It reinforces the company's internal controls around insider trading and corporate disclosures, which supports better governance standards.